TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AtrimusRX AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
297,454
|
189,762
|
157,137 |
Financial expenses |
2,512
|
86
|
94 |
Earnings before taxes |
51,524
|
39,887
|
26,688 |
EBITDA |
54,406
|
40,512
|
27,177 |
Total assets |
105,587
|
59,019
|
64,986 |
Current assets |
104,439
|
57,732
|
63,163 |
Current liabilities |
58,311
|
22,636
|
40,262 |
Equity capital |
47,276
|
36,383
|
24,724 |
- share capital |
72
![]() |
72
![]() |
72 |
Employees (average) |
7
![]() |
7
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
44.8%
|
61.6%
|
38.0% |
Turnover per employee |
42,493
|
27,109
|
17,460 |
Profit as a percentage of turnover |
17.3%
|
21.0%
|
17.0% |
Return on assets (ROA) |
51.2%
|
67.7%
|
41.2% |
Current ratio |
179.1%
|
255.0%
|
156.9% |
Return on equity (ROE) |
109.0%
|
109.6%
|
107.9% |
Change turnover |
107,692
|
32,625
|
17,875 |
Change turnover % |
57%
|
21%
|
13% |
Chg. No. of employees |
0
|
-2
|
1 |
Chg. No. of employees % |
0%
|
-22%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.